Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 26

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 26
---
 with individual directors, the non-management directors as a group or the entire
Board may do so by writing to the Nominating and Corporate Governance Committee, c/o Nominating and Corporate Governance Committee Chairman,
60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.

The Nominating and Corporate Governance Committee
has approved a process for handling letters received by the Company and addressed to individual directors, non-management members of the
Board or the Board. Under that process, the Chief Executive Officer and President of the Company reviews all such correspondence and regularly
forwards to a designated individual member of the Nominating and Corporate Governance Committee copies of all such correspondence (although
we do not forward commercial correspondence and correspondence duplicative in nature; however, we will retain duplicate correspondence
and all duplicate correspondence will be available for directors’ review upon their request) and a summary of all such correspondence.
The Chairman of the Nominating and Corporate Governance Committee will forward correspondence directed to individual directors as he deems
appropriate. Written correspondence from stockholders relating to accounting, internal controls or auditing matters are immediately brought
to the attention of the Company’s Audit Committee Chairman and handled in accordance with procedures established by the Audit Committee
with respect to such matters.

Board Committees

The Board of Directors has a standing Audit Committee,
Compensation Committee and Nominating and Corporate Governance Committee. The following table summarizes the members and functions of
the Board’s committees.

| Stephen Toovey |     | 71 |     | Director |     | 2021 |     | Nominating and Governance – Chairman; Audit; Nominating and Corporate Governance. |
| Charles Allen  |     | 49 |     | Director |     | 2021 |     | Audit – Chairman; Compensation; Nominating and Corporate Governance.              |
| Paul Field     |     | 62 |     | Director |     | 2021 |     | Compensation – Chairman; Compensation; Audit.                                     |

<div align='center'>13</div>

| Name of Committee and                         
 Its Members                                   | Functions of the Committee                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                          |
| Audit Committee:                              
 Charles Allen,                                
 Chairman; Stephen Toovey; Paul Field.         | ●                                                                                                                                                                                                                                                                               | reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the Board whether the audited financial statements should be included in our annual disclosure report; |
| ●                                             |